HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mikko Airavaara Selected Research

Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)

6/2008Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mikko Airavaara Research Topics

Disease

21Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2011
13Stroke (Strokes)
01/2021 - 01/2011
7Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 01/2010
5Infarction (Infarctions)
01/2020 - 07/2009
4Brain Injuries (Brain Injury)
10/2017 - 07/2009
3Neoplasms (Cancer)
11/2020 - 05/2007
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 01/2013
3Ischemia
01/2014 - 09/2010
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
2Neuralgia (Stump Neuralgia)
11/2020 - 01/2018
2Inflammation (Inflammations)
01/2020 - 10/2017
2Hyperalgesia
01/2019 - 01/2018
2Huntington Disease (Huntington's Disease)
12/2011 - 01/2011
2Alzheimer Disease (Alzheimer's Disease)
12/2011 - 01/2011
2Multiple Endocrine Neoplasia Type 2b (MEN 3)
06/2008 - 05/2007
1Gliosis
01/2022
1Synucleinopathies
01/2021
1Rheumatoid Arthritis
11/2020
1Multiple Sclerosis
11/2020
1Opiate Overdose
03/2018
1Ischemic Stroke
03/2018
1Reperfusion Injury
01/2018
1Neuroinflammatory Diseases
01/2017
1Neuroblastoma
02/2013
1Infections
01/2013
1Brain Diseases (Brain Disorder)
12/2011
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2011
1Brain Ischemia (Cerebral Ischemia)
07/2009
1Necrosis
07/2009
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
05/2007

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2007
12Nerve Growth Factors (Neurotrophins)IBA
06/2022 - 07/2009
11Dopamine (Intropin)FDA LinkGeneric
06/2022 - 05/2007
6SynucleinsIBA
01/2022 - 01/2020
4Oxidopamine (6 Hydroxydopamine)IBA
01/2019 - 04/2016
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2019 - 05/2007
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2018 - 12/2011
3Messenger RNA (mRNA)IBA
12/2011 - 05/2007
2LigandsIBA
01/2020 - 01/2014
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2018
2Pharmaceutical PreparationsIBA
03/2018 - 10/2017
2Protein Isoforms (Isoforms)IBA
01/2018 - 12/2011
1Insulin (Novolin)FDA Link
01/2022
1Amyloidogenic ProteinsIBA
01/2022
1Bromocriptine (Parlodel)FDA LinkGeneric
01/2021
1Protein AggregatesIBA
01/2021
1GuanosineIBA
01/2020
1enhanced green fluorescent proteinIBA
01/2020
1AdenineFDA LinkGeneric
01/2020
1Adenosine (Adenocard)FDA LinkGeneric
01/2020
1Calcium-Binding ProteinsIBA
01/2020
1CeramidesIBA
01/2020
1Culture MediaIBA
01/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2020
1salicylhydroxamic acid (SHAM)IBA
01/2020
1NeurotoxinsIBA
01/2020
1SiliconIBA
01/2020
1Sugar PhosphatesIBA
01/2020
1Naloxone (Narcan)FDA LinkGeneric
03/2018
1Opioid Receptors (Opioid Receptor)IBA
03/2018
1Morphine (MS Contin)FDA LinkGeneric
01/2018
1Recombinant ProteinsIBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2017
1AlitretinoinFDA Link
01/2017
1lactacystinIBA
01/2017
1Bromodeoxyuridine (BrdU)IBA
01/2017
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2017
1NeurturinIBA
12/2016
1Hormones (Hormone)IBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2016
1IncretinsIBA
01/2016
1Chemotactic FactorsIBA
01/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014
1Dietary ProteinsIBA
01/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2014
1Amino AcidsFDA Link
02/2013
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2011
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2011
1Glutamic Acid (Glutamate)FDA Link
01/2011
1Neuroprotective AgentsIBA
07/2009
1Arginine (L-Arginine)FDA Link
07/2009
1triphenyltetrazoliumIBA
07/2009
1Tetrabenazine (Nitoman)FDA Link
06/2008
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2008
1alpha-Methyltyrosine (Metirosine)FDA Link
06/2008
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2007
1Cocaine (Cocaine HCl)IBA
05/2007

Therapy/Procedure

6Therapeutics
11/2020 - 01/2010
1Electrodes (Electrode)
01/2022
1Intranasal Administration
03/2018
1Injections
01/2018
1Deep Brain Stimulation
01/2018
1Drug Therapy (Chemotherapy)
01/2017
1Vascular Surgical Procedures
01/2014
1Diet Therapy (Therapy, Diet)
01/2014
1Protein-Restricted Diet (Diet, Protein Restricted)
01/2014